// company-profile

Oruka Therapeutics, Inc.

ORKA
ExchangeNasdaqSectorPharmaceutical PreparationsInc.DEFilings59Insiders31
// api This Oruka Therapeutics, Inc. insider-trading data is served live by the Form4API insider trading API. Get the same data via API.

// activity-summary

Recent insider activity is bullish. Over the last 30 days, 13 insiders purchased shares versus 5 sales. Buying was led by Agarwal Arjun.

// 90-day insight

Over the last 90 days, Oruka Therapeutics, Inc. insiders bought $922K (25 transactions) and sold $307K (5 transactions).

  • Most active insider: Agarwal Arjun with 18 transactions totaling $1.8M.
  • Largest single sale: $3.2M by Dambkowski Carl on May 21, 2026.
  • 80% of recent sales were pre-scheduled 10b5-1 trades — typically less informative than open-market activity.

Activity skews bullish — buys outpace sales.

Institutional Ownership

Top 13F-HR holders of Oruka Therapeutics, Inc. as of 2026-03-31

↑ increasing
Total reported AUM
$2.48B
QoQ change
+78.2%
Reporting period
2026-03-31
#1
FMR LLC
CIK 315066
$309.0M
6.3M shares
#2
Venrock Adviser, LLC
CIK 1615982
$203.5M
4.1M shares
#3
Fairmount Funds Management LLC
CIK 1802528
$181.7M
3.7M shares

Data source: SEC Form 13F-HR filings. Joined with insider activity above — see who's loading up institutionally while insiders are trading. Full 13F-HR API →

Insider Transactions

Sourced from SEC EDGAR Form 4 filings. Updated hourly.

DateInsiderCompanyTypeSharesPriceValue
Jun 22, 2026Agarwal ArjunORKA
Sale10b5
888$80.01$71K
Jun 22, 2026Agarwal ArjunORKA
Sale10b5
699$82.14$57K
Jun 15, 2026Klein Lawrence OttoORKA
Sale
1,729$69.69$120K
Jun 15, 2026Goncalves JoanaORKA
Option Exercise
3,500$0.00$0K
Jun 15, 2026Goncalves JoanaORKA
Sale10b5
1,636$68.38$112K

45 more transactions hidden

Free account · No credit card required

Building something? Get API access →

Popular companies on Form4API

Browse insider trading activity for other actively-filed companies.